fashion -WSS

fashion

author：Wikipedia 2025-09-30 18:59:22 - browse：53

Matts Take Column Illustration — Molly Ferguson for STAT

If you’re a drug company executive, you probably feel like you got up on the wrong side of bed.

On Thursday night, President Biden proposed expanding one of his most popular policies: the Medicare price negotiation process that was put in place as part of the Inflation Reduction Act. “Americans pay more for prescription drugs than anywhere else,” Biden said. “It’s wrong and I’m ending it.”

Obviously, the drug industry is not going to be happy about new price limitations in the U.S., the biggest market for pharmaceuticals. But, even more than that, Biden’s move emphasizes a painful reality: That pharmaceutical companies remain one of the biggest political targets in the country — despite their key role in addressing the Covid-19 pandemic and their development of wildly effective new weight loss drugs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Steward Health Care Massachusetts hospitals face fiscal disaster

leisure time

WSS

HHS secretary Becerra pressed on Change HealthCare cyberattack

First U.S. drug developed to treat liver disease MASH is approved

How many hemophilia patients actually want gene therapy?

Pushing for an NIH office for post

Cigna, Humana reportedly in talks to merge

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

entertainment

fashion

focus

The high cost of giving birth even with insurance

Why depression after traumatic brain injury is distinct

Continuity nursing helped my family in our darkest PICU moments

First U.S. drug developed to treat liver disease MASH is approved

In Memoriam: Notable people who died in 2023

Pediatric cancer treatments threatened by a new FDA policy

Peter Hotez and the public health issue of online harassment

Bayer exec: U.S. is key in reviving beleaguered pharma’s drug pipeline

Anesthesiologist group: stop taking Ozempic before surgery

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

hotspot

Diagnostic tests are hitting their mathematical limits

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

President Biden's budget: Here's what you might have missed

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Takeda, Janssen join wearable maker to measure scratching

The EPA's new lead rule: How one expert crunched the numbers

hotspot

leisure time

explore

focus